Monthly
US$200
Billed every month
Empagliflozin Tablets(恩格列净片)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 3 applicationsNo longer listed under review: 3 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders47View records ↓
Under-review filings18View records ↓
This year’s generic filers4View records ↓
NHSA approval numbers79View records ↓
API companies with A status34View records ↓
Chemical-drug catalogue
Loaded records: 47 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 46 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 东北制药集团沈阳第一制药有限公司 | 东北制药集团沈阳第一制药有限公司 | 国药准字H20265837 | 2026/09/02 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东益康药业股份有限公司 | 山东益康药业股份有限公司 | 国药准字H20264493 | 2026/05/27 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东益康药业股份有限公司 | 山东益康药业股份有限公司 | 国药准字H20264394 | 2026/05/19 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 郑州泰丰制药有限公司 | 郑州泰丰制药有限公司 | 国药准字H20263272 | 2026/01/27 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 郑州泰丰制药有限公司 | 郑州泰丰制药有限公司 | 国药准字H20263271 | 2026/01/27 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 沐邦（北京）医药科技有限公司 | 河北亚诺生物科技集团股份有限公司 | 国药准字H20256275 | 2025/12/16 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 沐邦（北京）医药科技有限公司 | 河北亚诺生物科技集团股份有限公司 | 国药准字H20256274 | 2025/12/16 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川依科制药有限公司 | 四川依科制药有限公司 | 国药准字H20256123 | 2025/12/03 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川依科制药有限公司 | 四川依科制药有限公司 | 国药准字H20256122 | 2025/12/03 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东鲁宁药业有限公司 | 山东鲁宁药业有限公司 | 国药准字H20256043 | 2025/11/25 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东鲁宁药业有限公司 | 山东鲁宁药业有限公司 | 国药准字H20256044 | 2025/11/25 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄市普力制药有限公司 | 石家庄市普力制药有限公司 | 国药准字H20255964 | 2025/11/18 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄市普力制药有限公司 | 石家庄市普力制药有限公司 | 国药准字H20255963 | 2025/11/18 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 2025/09/30 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 2025/09/30 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏康缘药业股份有限公司 | 江苏康缘药业股份有限公司 | 国药准字H20255561 | 2025/09/23 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 云鹏医药集团有限公司 | 云鹏医药集团有限公司 | 国药准字H20255559 | 2025/09/23 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏康缘药业股份有限公司 | 江苏康缘药业股份有限公司 | 国药准字H20255560 | 2025/09/23 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东新时代药业有限公司 | 山东新时代药业有限公司 | 国药准字H20258197 | 2025/09/12 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 佑华医药科技有限公司 | 重庆华森制药股份有限公司 | 国药准字H20255257 | 2025/08/26 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 佑华医药科技有限公司 | 重庆华森制药股份有限公司 | 国药准字H20255258 | 2025/08/26 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江宏元药业股份有限公司 | 浙江京新药业股份有限公司 | 国药准字H20254949 | 2025/07/22 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 深圳奥萨制药有限公司 | 深圳奥萨制药有限公司 | 国药准字H20254763 | 2025/06/30 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 烟台鲁银药业有限公司 | 烟台鲁银药业有限公司 | 国药准字H20254607 | 2025/06/24 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏海岸药业有限公司 | 江苏海岸药业有限公司 | 国药准字H20258032 | 2025/03/19 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都恒瑞制药有限公司 | 成都恒瑞制药有限公司 | 国药准字H20253500 | 2025/03/04 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南汉森制药股份有限公司 | 湖南汉森制药股份有限公司 | 国药准字H20253232 | 2025/01/24 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 甘李药业山东有限公司 | 华益药业科技（安徽）有限公司 | 国药准字H20253229 | 2025/01/24 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东新华制药股份有限公司 | 山东新华制药股份有限公司 | 国药准字H20253201 | 2025/01/14 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 惠升生物制药股份有限公司 | 南京海纳制药有限公司 | 国药准字H20249836 | 2024/12/25 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 惠升生物制药股份有限公司 | 南京海纳制药有限公司 | 国药准字H20249837 | 2024/12/25 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南迪诺制药股份有限公司 | 湖南迪诺制药股份有限公司 | 国药准字H20249556 | 2024/12/01 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 合肥国高药业有限公司 | 华益药业科技（安徽）有限公司 | 国药准字H20249429 | 2024/11/22 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东新时代药业有限公司 | 山东新时代药业有限公司 | 国药准字H20249148 | 2024/10/22 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南汉森制药股份有限公司 | 湖南汉森制药股份有限公司 | 国药准字H20249057 | 2024/10/16 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 天地恒一制药股份有限公司 | 天地恒一制药股份有限公司 | 国药准字H20247161 | 2024/07/11 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南九典制药股份有限公司 | 湖南九典制药股份有限公司 | 国药准字H20244173 | 2024/06/28 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江诺得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20244088 | 2024/06/18 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江诺得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20244089 | 2024/06/18 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华义制药有限公司 | 浙江华义制药有限公司 | 国药准字H20247122 | 2024/06/07 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宁波大红鹰药业股份有限公司 | 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 2024/06/04 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 国药集团容生制药有限公司 | 国药集团容生制药有限公司 | 国药准字H20243457 | 2024/04/07 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20243452 | 2024/04/07 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 国药集团容生制药有限公司 | 国药集团容生制药有限公司 | 国药准字H20243456 | 2024/04/07 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20243451 | 2024/04/07 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20243424 | 2024/04/07 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宁波美诺华天康药业有限公司 | 宁波美诺华天康药业有限公司 | 国药准字H20243351 | 2024/03/19 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州民生药业股份有限公司 | 杭州民生药业股份有限公司 | 国药准字H20243268 | 2024/02/23 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州民生药业股份有限公司 | 杭州民生药业股份有限公司 | 国药准字H20243267 | 2024/02/23 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 漳州水仙药业股份有限公司 | 山东朗诺制药有限公司 | 国药准字H20243001 | 2024/01/05 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 青岛黄海制药有限责任公司 | 青岛黄海制药有限责任公司 | 国药准字H20234686 | 2023/12/26 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 青岛黄海制药有限责任公司 | 青岛黄海制药有限责任公司 | 国药准字H20234685 | 2023/12/26 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 齐鲁制药（海南）有限公司 | 齐鲁制药（海南）有限公司 | 国药准字H20234642 | 2023/12/13 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 齐鲁制药（海南）有限公司 | 齐鲁制药（海南）有限公司 | 国药准字H20234641 | 2023/12/13 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 通化东宝药业股份有限公司 | 通化东宝药业股份有限公司 | 国药准字H20234217 | 2023/09/28 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 通化东宝药业股份有限公司 | 通化东宝药业股份有限公司 | 国药准字H20234216 | 2023/09/28 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 乐普药业股份有限公司 | 乐普药业股份有限公司 | 国药准字H20233894 | 2023/06/30 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 扬子江药业集团北京海燕药业有限公司 | 江苏海岸药业有限公司 | 国药准字H20233742 | 2023/06/21 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏德源药业股份有限公司 | 江苏德源药业股份有限公司 | 国药准字H20233732 | 2023/06/14 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州华东医药集团浙江华义制药有限公司 | 杭州华东医药集团浙江华义制药有限公司 | 国药准字H20233704 | 2023/06/14 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 天地恒一制药股份有限公司 | 天地恒一制药股份有限公司 | 国药准字H20233507 | 2023/04/28 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏奥赛康药业有限公司 | 江苏奥赛康药业有限公司 | 国药准字H20213858 | 2021/11/17 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏万邦生化医药集团有限责任公司 | 江苏万邦生化医药集团有限责任公司 | 国药准字H20213115 | 2021/02/02 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 正大天晴药业集团股份有限公司 | 正大天晴药业集团股份有限公司 | 国药准字H20213065 | 2021/01/30 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 正大天晴药业集团股份有限公司 | 正大天晴药业集团股份有限公司 | 国药准字H20213066 | 2021/01/30 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川科伦药业股份有限公司 | 四川科伦药业股份有限公司 | 国药准字H20203410 | 2020/08/12 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川科伦药业股份有限公司 | 四川科伦药业股份有限公司 | 国药准字H20203411 | 2020/08/12 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏豪森药业集团有限公司 | 江苏豪森药业集团有限公司 | 国药准字H20203363 | 2020/07/29 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏豪森药业集团有限公司 | 江苏豪森药业集团有限公司 | 国药准字H20203364 | 2020/07/29 | 25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20170351 | 2017/09/20 | 10mg | Imported originator drug (进口原研药品) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 79 distinct approval numbers and 46 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 山东鑫齐药业有限公司 | 国药准字H20265830 | 25mg | Category B (乙) | XA10BKE079A001010104189 | NHSA |
| 山东益康药业股份有限公司 | 国药准字H20264493 | 10mg | Category B (乙) | XA10BKE079A001010104193 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263271 | 10mg | Category B (乙) | XA10BKE079A001010107011 | NHSA |
| 山东鑫齐药业有限公司 | 国药准字H20265830 | 25mg | Category B (乙) | XA10BKE079A001010204189 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263271 | 10mg | Category B (乙) | XA10BKE079A001010207011 | NHSA |
| 山东鑫齐药业有限公司 | 国药准字H20265830 | 25mg | Category B (乙) | XA10BKE079A001010304189 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263271 | 10mg | Category B (乙) | XA10BKE079A001010307011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263271 | 10mg | Category B (乙) | XA10BKE079A001010407011 | NHSA |
| 山东鑫齐药业有限公司 | 国药准字H20265829 | 10mg | Category B (乙) | XA10BKE079A001020104189 | NHSA |
| 山东益康药业股份有限公司 | 国药准字H20264394 | 25mg | Category B (乙) | XA10BKE079A001020104193 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263272 | 25mg | Category B (乙) | XA10BKE079A001020107011 | NHSA |
| 山东鑫齐药业有限公司 | 国药准字H20265829 | 10mg | Category B (乙) | XA10BKE079A001020204189 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263272 | 25mg | Category B (乙) | XA10BKE079A001020207011 | NHSA |
| 山东鑫齐药业有限公司 | 国药准字H20265829 | 10mg | Category B (乙) | XA10BKE079A001020304189 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263272 | 25mg | Category B (乙) | XA10BKE079A001020307011 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20263272 | 25mg | Category B (乙) | XA10BKE079A001020407011 | NHSA |
| 江苏海岸药业有限公司 | 国药准字H20233742 | 25mg | Category B (乙) | XA10BKE079A001010100237 | NHSA |
| Boehringer Ingelheim International GmbH | 国药准字J20171073 | 10mg | Category B (乙) | XA10BKE079A001010100638 | NHSA |
| 江苏奥赛康药业有限公司 | 国药准字H20213858 | 10mg | Category B (乙) | XA10BKE079A001010101425 | NHSA |
| 江苏豪森药业集团有限公司 | 国药准字H20203363 | 10mg | Category B (乙) | XA10BKE079A001010101444 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20255560 | 10mg | Category B (乙) | XA10BKE079A001010101463 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213065 | 10mg | Category B (乙) | XA10BKE079A001010101523 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20213115 | 10mg | Category B (乙) | XA10BKE079A001010101729 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20243424 | 10mg | Category B (乙) | XA10BKE079A001010102013 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20253500 | 10mg | Category B (乙) | XA10BKE079A001010102031 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203411 | 10mg | Category B (乙) | XA10BKE079A001010102180 | NHSA |
| 四川依科制药有限公司 | 国药准字H20256122 | 10mg | Category B (乙) | XA10BKE079A001010102251 | NHSA |
| 云鹏医药集团有限公司 | 国药准字H20255559 | 25mg | Category B (乙) | XA10BKE079A001010102968 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233894 | 25mg | Category B (乙) | XA10BKE079A001010103094 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010103205 | NHSA |
| 通化东宝药业股份有限公司 | 国药准字H20234216 | 10mg | Category B (乙) | XA10BKE079A001010103546 | NHSA |
| 康臣药业(内蒙古)有限责任公司 | 国药准字H20255356 | 10mg | Category B (乙) | XA10BKE079A001010103884 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20234685 | 10mg | Category B (乙) | XA10BKE079A001010104043 | NHSA |
| 山东鲁宁药业有限公司 | 国药准字H20256044 | 25mg | Category B (乙) | XA10BKE079A001010104104 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20253201 | 10mg | Category B (乙) | XA10BKE079A001010104187 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20249148 | 10mg | Category B (乙) | XA10BKE079A001010104188 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20254607 | 10mg | Category B (乙) | XA10BKE079A001010104240 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H20243267 | 25mg | Category B (乙) | XA10BKE079A001010104494 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010104554 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20243351 | 10mg | Category B (乙) | XA10BKE079A001010104565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243452 | 10mg | Category B (乙) | XA10BKE079A001010104647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20247122 | 10mg | Category B (乙) | XA10BKE079A001010104650 | NHSA |
| 湖南迪诺制药股份有限公司 | 国药准字H20249556 | 10mg | Category B (乙) | XA10BKE079A001010104914 | NHSA |
| 湖南汉森制药股份有限公司 | 国药准字H20249057 | 25mg | Category B (乙) | XA10BKE079A001010104925 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20244173 | 10mg | Category B (乙) | XA10BKE079A001010104942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 10mg | Category B (乙) | XA10BKE079A001010104960 | NHSA |
| 齐鲁制药(海南)有限公司 | 国药准字H20234642 | 10mg | Category B (乙) | XA10BKE079A001010105847 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20233732 | 10mg | Category B (乙) | XA10BKE079A001010106632 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001010107340 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010109637 | NHSA |
| 深圳奥萨制药有限公司 | 国药准字H20254763 | 10mg | Category B (乙) | XA10BKE079A001010179306 | NHSA |
| Boehringer Ingelheim International GmbH | H20170351 | 10mg | Category B (乙) | XA10BKE079A001010180023 | NHSA |
| 天地恒一制药股份有限公司 | 国药准字H20233507 | 25mg | Category B (乙) | XA10BKE079A001010180086 | NHSA |
| 江苏海岸药业有限公司 | 国药准字H20258032 | 10mg | Category B (乙) | XA10BKE079A001010182745 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20249836 | 25mg | Category B (乙) | XA10BKE079A001010183342 | NHSA |
| 佑华医药科技有限公司 | 国药准字H20255257 | 10mg | Category B (乙) | XA10BKE079A001010183461 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244088 | 25mg | Category B (乙) | XA10BKE079A001010183521 | NHSA |
| 合肥国高药业有限公司 | 国药准字H20249429 | 10mg | Category B (乙) | XA10BKE079A001010183883 | NHSA |
| 沐邦(北京)医药科技有限公司 | 国药准字H20256274 | 25mg | Category B (乙) | XA10BKE079A001010184950 | NHSA |
| 甘李药业山东有限公司 | 国药准字H20253229 | 10mg | Category B (乙) | XA10BKE079A001010185033 | NHSA |
| 漳州水仙药业股份有限公司 | 国药准字H20243001 | 10mg | Category B (乙) | XA10BKE079A001010185291 | NHSA |
| 江苏奥赛康药业有限公司 | 国药准字H20213858 | 10mg | Category B (乙) | XA10BKE079A001010201425 | NHSA |
| 江苏豪森药业集团有限公司 | 国药准字H20203363 | 10mg | Category B (乙) | XA10BKE079A001010201444 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213065 | 10mg | Category B (乙) | XA10BKE079A001010201523 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20213115 | 10mg | Category B (乙) | XA10BKE079A001010201729 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20243424 | 10mg | Category B (乙) | XA10BKE079A001010202013 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203411 | 10mg | Category B (乙) | XA10BKE079A001010202180 | NHSA |
| 四川依科制药有限公司 | 国药准字H20256122 | 10mg | Category B (乙) | XA10BKE079A001010202251 | NHSA |
| 云鹏医药集团有限公司 | 国药准字H20255559 | 25mg | Category B (乙) | XA10BKE079A001010202968 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233894 | 25mg | Category B (乙) | XA10BKE079A001010203094 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010203205 | NHSA |
| 通化东宝药业股份有限公司 | 国药准字H20234216 | 10mg | Category B (乙) | XA10BKE079A001010203546 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20234685 | 10mg | Category B (乙) | XA10BKE079A001010204043 | NHSA |
| 山东鲁宁药业有限公司 | 国药准字H20256044 | 25mg | Category B (乙) | XA10BKE079A001010204104 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20253201 | 10mg | Category B (乙) | XA10BKE079A001010204187 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20249148 | 10mg | Category B (乙) | XA10BKE079A001010204188 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20254607 | 10mg | Category B (乙) | XA10BKE079A001010204240 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H20243267 | 25mg | Category B (乙) | XA10BKE079A001010204494 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010204554 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20243351 | 10mg | Category B (乙) | XA10BKE079A001010204565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243452 | 10mg | Category B (乙) | XA10BKE079A001010204647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20247122 | 10mg | Category B (乙) | XA10BKE079A001010204650 | NHSA |
| 湖南迪诺制药股份有限公司 | 国药准字H20249556 | 10mg | Category B (乙) | XA10BKE079A001010204914 | NHSA |
| 湖南汉森制药股份有限公司 | 国药准字H20249057 | 25mg | Category B (乙) | XA10BKE079A001010204925 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20244173 | 10mg | Category B (乙) | XA10BKE079A001010204942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 10mg | Category B (乙) | XA10BKE079A001010204960 | NHSA |
| 齐鲁制药(海南)有限公司 | 国药准字H20234642 | 10mg | Category B (乙) | XA10BKE079A001010205847 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20233732 | 10mg | Category B (乙) | XA10BKE079A001010206632 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010209637 | NHSA |
| 深圳奥萨制药有限公司 | 国药准字H20254763 | 10mg | Category B (乙) | XA10BKE079A001010279306 | NHSA |
| Boehringer Ingelheim International GmbH | 国药准字HJ20201008 | 10mg | Category B (乙) | XA10BKE079A001010280023 | NHSA |
| 天地恒一制药股份有限公司 | 国药准字H20233507 | 25mg | Category B (乙) | XA10BKE079A001010280086 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20249836 | 25mg | Category B (乙) | XA10BKE079A001010283342 | NHSA |
| 佑华医药科技有限公司 | 国药准字H20255257 | 10mg | Category B (乙) | XA10BKE079A001010283461 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244088 | 25mg | Category B (乙) | XA10BKE079A001010283521 | NHSA |
| 合肥国高药业有限公司 | 国药准字H20249429 | 10mg | Category B (乙) | XA10BKE079A001010283883 | NHSA |
| 甘李药业山东有限公司 | 国药准字H20253229 | 10mg | Category B (乙) | XA10BKE079A001010285033 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213065 | 10mg | Category B (乙) | XA10BKE079A001010301523 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20213115 | 10mg | Category B (乙) | XA10BKE079A001010301729 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20243424 | 10mg | Category B (乙) | XA10BKE079A001010302013 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203411 | 10mg | Category B (乙) | XA10BKE079A001010302180 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233894 | 25mg | Category B (乙) | XA10BKE079A001010303094 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010303205 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20253201 | 10mg | Category B (乙) | XA10BKE079A001010304187 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20249148 | 10mg | Category B (乙) | XA10BKE079A001010304188 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20254607 | 10mg | Category B (乙) | XA10BKE079A001010304240 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010304554 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20243351 | 10mg | Category B (乙) | XA10BKE079A001010304565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243452 | 10mg | Category B (乙) | XA10BKE079A001010304647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20247122 | 10mg | Category B (乙) | XA10BKE079A001010304650 | NHSA |
| 湖南迪诺制药股份有限公司 | 国药准字H20249556 | 10mg | Category B (乙) | XA10BKE079A001010304914 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20244173 | 10mg | Category B (乙) | XA10BKE079A001010304942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 10mg | Category B (乙) | XA10BKE079A001010304960 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20233732 | 10mg | Category B (乙) | XA10BKE079A001010306632 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010309637 | NHSA |
| 深圳奥萨制药有限公司 | 国药准字H20254763 | 10mg | Category B (乙) | XA10BKE079A001010379306 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20249836 | 25mg | Category B (乙) | XA10BKE079A001010383342 | NHSA |
| 佑华医药科技有限公司 | 国药准字H20255257 | 10mg | Category B (乙) | XA10BKE079A001010383461 | NHSA |
| 合肥国高药业有限公司 | 国药准字H20249429 | 10mg | Category B (乙) | XA10BKE079A001010383883 | NHSA |
| 甘李药业山东有限公司 | 国药准字H20253229 | 10mg | Category B (乙) | XA10BKE079A001010385033 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213065 | 10mg | Category B (乙) | XA10BKE079A001010401523 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20213115 | 10mg | Category B (乙) | XA10BKE079A001010401729 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20243424 | 10mg | Category B (乙) | XA10BKE079A001010402013 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203411 | 10mg | Category B (乙) | XA10BKE079A001010402180 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010403205 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20253201 | 10mg | Category B (乙) | XA10BKE079A001010404187 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20249148 | 10mg | Category B (乙) | XA10BKE079A001010404188 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20254607 | 10mg | Category B (乙) | XA10BKE079A001010404240 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010404554 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243452 | 10mg | Category B (乙) | XA10BKE079A001010404647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20247122 | 10mg | Category B (乙) | XA10BKE079A001010404650 | NHSA |
| 湖南迪诺制药股份有限公司 | 国药准字H20249556 | 10mg | Category B (乙) | XA10BKE079A001010404914 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20244173 | 10mg | Category B (乙) | XA10BKE079A001010404942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 10mg | Category B (乙) | XA10BKE079A001010404960 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20233732 | 10mg | Category B (乙) | XA10BKE079A001010406632 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010409637 | NHSA |
| 深圳奥萨制药有限公司 | 国药准字H20254763 | 10mg | Category B (乙) | XA10BKE079A001010479306 | NHSA |
| Boehringer Ingelheim International GmbH | 国药准字HJ20171231 | 10mg | Category B (乙) | XA10BKE079A001010480023 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20249836 | 25mg | Category B (乙) | XA10BKE079A001010483342 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213065 | 10mg | Category B (乙) | XA10BKE079A001010501523 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20213115 | 10mg | Category B (乙) | XA10BKE079A001010501729 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203411 | 10mg | Category B (乙) | XA10BKE079A001010502180 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010503205 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20253201 | 10mg | Category B (乙) | XA10BKE079A001010504187 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20249148 | 10mg | Category B (乙) | XA10BKE079A001010504188 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20254607 | 10mg | Category B (乙) | XA10BKE079A001010504240 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010504554 | NHSA |
| 湖南迪诺制药股份有限公司 | 国药准字H20249556 | 10mg | Category B (乙) | XA10BKE079A001010504914 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20244173 | 10mg | Category B (乙) | XA10BKE079A001010504942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 10mg | Category B (乙) | XA10BKE079A001010504960 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20233732 | 10mg | Category B (乙) | XA10BKE079A001010506632 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010509637 | NHSA |
| 深圳奥萨制药有限公司 | 国药准字H20254763 | 10mg | Category B (乙) | XA10BKE079A001010579306 | NHSA |
| Boehringer Ingelheim International GmbH | 国药准字HJ20170351 | 10mg | Category B (乙) | XA10BKE079A001010580023 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213065 | 10mg | Category B (乙) | XA10BKE079A001010601523 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20213115 | 10mg | Category B (乙) | XA10BKE079A001010601729 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203411 | 10mg | Category B (乙) | XA10BKE079A001010602180 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010603205 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20253201 | 10mg | Category B (乙) | XA10BKE079A001010604187 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20249148 | 10mg | Category B (乙) | XA10BKE079A001010604188 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010604554 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20244173 | 10mg | Category B (乙) | XA10BKE079A001010604942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 10mg | Category B (乙) | XA10BKE079A001010604960 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20233732 | 10mg | Category B (乙) | XA10BKE079A001010606632 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010609637 | NHSA |
| 深圳奥萨制药有限公司 | 国药准字H20254763 | 10mg | Category B (乙) | XA10BKE079A001010679306 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20213115 | 10mg | Category B (乙) | XA10BKE079A001010701729 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203411 | 10mg | Category B (乙) | XA10BKE079A001010702180 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010703205 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010704554 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 10mg | Category B (乙) | XA10BKE079A001010704960 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010709637 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010803205 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010804554 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255611 | 10mg | Category B (乙) | XA10BKE079A001010804960 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010809637 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001010903205 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001010904554 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001010909637 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001011003205 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001011004554 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011009637 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243456 | 10mg | Category B (乙) | XA10BKE079A001011103205 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001011104554 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011109637 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001011204554 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011209637 | NHSA |
| 宁波大红鹰药业股份有限公司 | 国药准字H20243952 | 10mg | Category B (乙) | XA10BKE079A001011304554 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011309637 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011409637 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011509637 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011609637 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011709637 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001011809637 | NHSA |
| Boehringer Ingelheim International GmbH | 国药准字J20171074 | 25mg | Category B (乙) | XA10BKE079A001020100638 | NHSA |
| 江苏豪森药业集团有限公司 | 国药准字H20203364 | 25mg | Category B (乙) | XA10BKE079A001020101444 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20255561 | 25mg | Category B (乙) | XA10BKE079A001020101463 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213066 | 25mg | Category B (乙) | XA10BKE079A001020101523 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20213115 | 10mg | Category B (乙) | XA10BKE079A001020101729 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203410 | 25mg | Category B (乙) | XA10BKE079A001020102180 | NHSA |
| 四川依科制药有限公司 | 国药准字H20256123 | 25mg | Category B (乙) | XA10BKE079A001020102251 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233895 | 10mg | Category B (乙) | XA10BKE079A001020103094 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243457 | 25mg | Category B (乙) | XA10BKE079A001020103205 | NHSA |
| 通化东宝药业股份有限公司 | 国药准字H20234217 | 25mg | Category B (乙) | XA10BKE079A001020103546 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20234686 | 25mg | Category B (乙) | XA10BKE079A001020104043 | NHSA |
| 山东鲁宁药业有限公司 | 国药准字H20256043 | 10mg | Category B (乙) | XA10BKE079A001020104104 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20258197 | 25mg | Category B (乙) | XA10BKE079A001020104188 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H20243268 | 10mg | Category B (乙) | XA10BKE079A001020104494 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243451 | 25mg | Category B (乙) | XA10BKE079A001020104647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20233704 | 25mg | Category B (乙) | XA10BKE079A001020104650 | NHSA |
| 湖南汉森制药股份有限公司 | 国药准字H20253232 | 10mg | Category B (乙) | XA10BKE079A001020104925 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 25mg | Category B (乙) | XA10BKE079A001020104960 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001020107340 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001020109637 | NHSA |
| Boehringer Ingelheim International GmbH | H20170352 | 25mg | Category B (乙) | XA10BKE079A001020180023 | NHSA |
| 天地恒一制药股份有限公司 | 国药准字H20247161 | 10mg | Category B (乙) | XA10BKE079A001020180086 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20249837 | 10mg | Category B (乙) | XA10BKE079A001020183342 | NHSA |
| 佑华医药科技有限公司 | 国药准字H20255258 | 25mg | Category B (乙) | XA10BKE079A001020183461 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020183521 | NHSA |
| 沐邦(北京)医药科技有限公司 | 国药准字H20256275 | 10mg | Category B (乙) | XA10BKE079A001020184950 | NHSA |
| 江苏豪森药业集团有限公司 | 国药准字H20203364 | 25mg | Category B (乙) | XA10BKE079A001020201444 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213066 | 25mg | Category B (乙) | XA10BKE079A001020201523 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203410 | 25mg | Category B (乙) | XA10BKE079A001020202180 | NHSA |
| 四川依科制药有限公司 | 国药准字H20256123 | 25mg | Category B (乙) | XA10BKE079A001020202251 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233895 | 10mg | Category B (乙) | XA10BKE079A001020203094 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243457 | 25mg | Category B (乙) | XA10BKE079A001020203205 | NHSA |
| 山东鲁宁药业有限公司 | 国药准字H20256043 | 10mg | Category B (乙) | XA10BKE079A001020204104 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20258197 | 25mg | Category B (乙) | XA10BKE079A001020204188 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H20243268 | 10mg | Category B (乙) | XA10BKE079A001020204494 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20233704 | 25mg | Category B (乙) | XA10BKE079A001020204650 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 25mg | Category B (乙) | XA10BKE079A001020204960 | NHSA |
| Boehringer Ingelheim International GmbH | 国药准字HJ20171232 | 25mg | Category B (乙) | XA10BKE079A001020280023 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20249837 | 10mg | Category B (乙) | XA10BKE079A001020283342 | NHSA |
| 佑华医药科技有限公司 | 国药准字H20255258 | 25mg | Category B (乙) | XA10BKE079A001020283461 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020283521 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213066 | 25mg | Category B (乙) | XA10BKE079A001020301523 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203410 | 25mg | Category B (乙) | XA10BKE079A001020302180 | NHSA |
| 四川依科制药有限公司 | 国药准字H20256123 | 25mg | Category B (乙) | XA10BKE079A001020302251 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233895 | 10mg | Category B (乙) | XA10BKE079A001020303094 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20243457 | 25mg | Category B (乙) | XA10BKE079A001020303205 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20258197 | 25mg | Category B (乙) | XA10BKE079A001020304188 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H20243268 | 10mg | Category B (乙) | XA10BKE079A001020304494 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20233704 | 25mg | Category B (乙) | XA10BKE079A001020304650 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 25mg | Category B (乙) | XA10BKE079A001020304960 | NHSA |
| Boehringer Ingelheim International GmbH | 国药准字HJ20170352 | 25mg | Category B (乙) | XA10BKE079A001020380023 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20249837 | 10mg | Category B (乙) | XA10BKE079A001020383342 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020383521 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213066 | 25mg | Category B (乙) | XA10BKE079A001020401523 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233895 | 10mg | Category B (乙) | XA10BKE079A001020403094 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20258197 | 25mg | Category B (乙) | XA10BKE079A001020404188 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20233704 | 25mg | Category B (乙) | XA10BKE079A001020404650 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 25mg | Category B (乙) | XA10BKE079A001020404960 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20249837 | 10mg | Category B (乙) | XA10BKE079A001020483342 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020483521 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213066 | 25mg | Category B (乙) | XA10BKE079A001020501523 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233895 | 10mg | Category B (乙) | XA10BKE079A001020503094 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20258197 | 25mg | Category B (乙) | XA10BKE079A001020504188 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 25mg | Category B (乙) | XA10BKE079A001020504960 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020583521 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20213066 | 25mg | Category B (乙) | XA10BKE079A001020601523 | NHSA |
| 乐普药业股份有限公司 | 国药准字H20233895 | 10mg | Category B (乙) | XA10BKE079A001020603094 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20258197 | 25mg | Category B (乙) | XA10BKE079A001020604188 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 25mg | Category B (乙) | XA10BKE079A001020604960 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020683521 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 25mg | Category B (乙) | XA10BKE079A001020704960 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020783521 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20255612 | 25mg | Category B (乙) | XA10BKE079A001020804960 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001020983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001021983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001022083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001022183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001022283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001022383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20244089 | 10mg | Category B (乙) | XA10BKE079A001022483521 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001030107340 | NHSA |
| 浙江宏元药业股份有限公司 | 国药准字H20254949 | 10mg | Category B (乙) | XA10BKE079A001030109637 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001040107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001050107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001060107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001070107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001080107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001090107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001100107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001110107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001120107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001130107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001140107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20255964 | 10mg | Category B (乙) | XA10BKE079A001150107340 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 18 filings and 11 distinct first applicants.
Generic 17 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 浙江海翔药业股份有限公司 | CYHS2602179 | Generic | 2026/09/01 | Not stated by source | CDE |
| 浙江海翔药业股份有限公司 | CYHS2602178 | Generic | 2026/09/01 | Not stated by source | CDE |
| 山东丹红制药有限公司;广州玻思韬控释药业有限公司 | CYHS2601744 | Generic | 2026/07/21 | Not stated by source | CDE |
| 郑州韩都药业集团有限公司 | CYHS2600332 | Generic | 2026/01/31 | Not stated by source | CDE |
| 郑州韩都药业集团有限公司 | CYHS2600331 | Generic | 2026/01/31 | Not stated by source | CDE |
| 石药集团欧意药业有限公司 | CYHS2600032 | Generic | 2026/01/05 | Not stated by source | CDE |
| 石药集团欧意药业有限公司 | CYHS2600031 | Generic | 2026/01/05 | Not stated by source | CDE |
| 合肥康惠医药技术有限公司;合肥立方制药股份有限公司 | CYHS2504159 | Generic | 2025/12/03 | Not stated by source | CDE |
| 浙江普洛康裕制药有限公司 | CYHS2504073 | Generic | 2025/11/26 | Not stated by source | CDE |
| 浙江普洛康裕制药有限公司 | CYHS2504072 | Generic | 2025/11/26 | Not stated by source | CDE |
| 广东彼迪药业有限公司 | CYHS2502508 | Generic | 2025/07/12 | Not stated by source | CDE |
| 广东彼迪药业有限公司 | CYHS2502506 | Generic | 2025/07/12 | Not stated by source | CDE |
| 江西迪赛诺医药集团有限公司 | CYHS2502413 | Generic | 2025/07/08 | Not stated by source | CDE |
| 江西迪赛诺医药集团有限公司 | CYHS2502412 | Generic | 2025/07/08 | Not stated by source | CDE |
| 德州博诚制药有限公司 | CYHS2502026 | Generic | 2025/06/07 | Not stated by source | CDE |
| 德州博诚制药有限公司 | CYHS2502025 | Generic | 2025/06/07 | Not stated by source | CDE |
| 吉林天力泰药业有限公司 | CYHS2501669 | Generic | 2025/05/08 | Not stated by source | CDE |
| 山东新华制药股份有限公司 | CYHB2601999 | Supplement | 2026/11/04 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 7 filings and 4 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 浙江海翔药业股份有限公司 | CYHS2602179 | Generic | 2026/09/01 | Not stated by source | CDE |
| 浙江海翔药业股份有限公司 | CYHS2602178 | Generic | 2026/09/01 | Not stated by source | CDE |
| 山东丹红制药有限公司;广州玻思韬控释药业有限公司 | CYHS2601744 | Generic | 2026/07/21 | Not stated by source | CDE |
| 郑州韩都药业集团有限公司 | CYHS2600332 | Generic | 2026/01/31 | Not stated by source | CDE |
| 郑州韩都药业集团有限公司 | CYHS2600331 | Generic | 2026/01/31 | Not stated by source | CDE |
| 石药集团欧意药业有限公司 | CYHS2600032 | Generic | 2026/01/05 | Not stated by source | CDE |
| 石药集团欧意药业有限公司 | CYHS2600031 | Generic | 2026/01/05 | Not stated by source | CDE |
API registrations
Non-component matches: 34 companies with A status and 9 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 恩格列净 | 安徽森吉制药有限公司 | Y20260000571 | I | Exact ingredient | 2026/07/22 | CDE |
| 恩格列净 | M/s. MSN Life Sciences Private Limited | Y20260000185 | I | Exact ingredient | 2026/05/14 | CDE |
| 恩格列净 | 江苏阿尔法集团福瑞药业（宿迁）有限公司 | Y20250001102 | I | Exact ingredient | 2026/04/03 | CDE |
| 恩格列净 | 阜新龙瑞药业有限责任公司 | Y20250001250 | I | Exact ingredient | 2026/01/04 | CDE |
| 恩格列净 | 迪嘉药业集团股份有限公司 | Y20250000619 | I | Exact ingredient | 2025/09/05 | CDE |
| 恩格列净 | 长春海悦药业股份有限公司 | Y20250000684 | I | Exact ingredient | 2025/08/08 | CDE |
| 恩格列净 | 华东医药（西安）博华制药有限公司 | Y20240001566 | A | Exact ingredient | 2026/09/03 | CDE |
| 恩格列净 | 云鹏医药集团有限公司 | Y20240001088 | A | Exact ingredient | 2026/03/13 | CDE |
| 恩格列净 | 山东铂源药业股份有限公司 | Y20240001013 | A | Exact ingredient | 2026/05/21 | CDE |
| 恩格列净 | KRKA, d.d., Novo mesto | Y20240000407 | A | Exact ingredient | 2025/12/01 | CDE |
| 恩格列净 | 浙江江北南海药业有限公司 | Y20240000308 | A | Exact ingredient | 2025/12/18 | CDE |
| 恩格列净 | 辽宁北峰药业有限公司 | Y20240000080 | A | Exact ingredient | 2026/09/25 | CDE |
| 恩格列净 | 浙江尖峰药业有限公司 | Y20240000088 | A | Exact ingredient | 2026/10/15 | CDE |
| 恩格列净 | 山东益康药业股份有限公司 | Y20230001305 | A | Exact ingredient | 2025/07/25 | CDE |
| 恩格列净 | Biocon Limited | Y20230000679 | A | Exact ingredient | 2026/09/14 | CDE |
| 恩格列净 | 浙江华海药业股份有限公司 | Y20230000862 | A | Exact ingredient | 2025/02/19 | CDE |
| 恩格列净 | 东北制药集团股份有限公司 | Y20230000623 | A | Exact ingredient | 2024/12/16 | CDE |
| 恩格列净 | Alembic Pharmaceuticals Limited | Y20220001142 | A | Exact ingredient | 2025/08/11 | CDE |
| 恩格列净 | 湖南九典宏阳制药有限公司 | Y20220001228 | A | Exact ingredient | 2025/07/08 | CDE |
| 恩格列净 | 福安药业集团重庆博圣制药有限公司 | Y20220001173 | A | Exact ingredient | 2025/07/16 | CDE |
| 恩格列净 | 浙江天宇药业股份有限公司 | Y20220000965 | A | Exact ingredient | 2025/04/02 | CDE |
| 恩格列净 | 浙江宏元药业股份有限公司 | Y20220000943 | A | Exact ingredient | 2025/11/22 | CDE |
| 恩格列净 | 江西同和药业股份有限公司 | Y20220001013 | A | Exact ingredient | 2026/07/28 | CDE |
| 恩格列净 | 浙江昌海制药有限公司 | Y20220000838 | A | Exact ingredient | 2025/03/06 | CDE |
| 恩格列净 | 宣城美诺华药业有限公司 | Y20220000587 | A | Exact ingredient | 2024/02/08 | CDE |
| 恩格列净 | 浙江华海药业股份有限公司 | Y20220000565 | A | Exact ingredient | 2025/10/20 | CDE |
| 恩格列净 | Morepen Laboratories Ltd | Y20220000265 | I | Exact ingredient | 2024/02/02 | CDE |
| 恩格列净 | 通化东宝药业股份有限公司 | Y20220000005 | A | Exact ingredient | 2023/10/15 | CDE |
| 恩格列净 | 山东朗诺制药有限公司 | Y20210001250 | A | Exact ingredient | 2024/08/08 | CDE |
| 恩格列净 | 天地恒一制药股份有限公司 | Y20210001202 | A | Exact ingredient | 2026/07/02 | CDE |
| 恩格列净 | 江苏德源药业股份有限公司 | Y20210000996 | A | Exact ingredient | 2024/03/16 | CDE |
| 恩格列净 | 乐普药业股份有限公司 | Y20210000790 | A | Exact ingredient | 2024/01/17 | CDE |
| 恩格列净 | 浙江朗华制药有限公司 | Y20200001182 | A | Exact ingredient | 2023/04/13 | CDE |
| 恩格列净 | Lupin Manufacturing Solutions Limited | Y20210000161 | A | Exact ingredient | 2024/10/24 | CDE |
| 恩格列净 | 扬子江药业集团江苏海慈生物药业有限公司 | Y20200001328 | A | Exact ingredient | 2023/06/29 | CDE |
| 恩格列净 | 南京海润医药有限公司 | Y20200000247 | A | Exact ingredient | 2026/08/25 | CDE |
| 恩格列净 | 浙江华义制药有限公司 | Y20190021274 | A | Exact ingredient | 2026/06/02 | CDE |
| 恩格列净 | Pharmaceutical Works Polpharma S.A. | Y20190000522 | I | Exact ingredient | 2019/11/20 | CDE |
| 恩格列净 | Laurus Labs Limited,(Unit-3) | Y20190000789 | A | Exact ingredient | 2025/03/06 | CDE |
| 恩格列净 | 徐州万邦金桥制药有限公司 | Y20190000220 | A | Exact ingredient | 2025/12/23 | CDE |
| 恩格列净 | 连云港润众制药有限公司 | Y20180001387 | A | Exact ingredient | 2025/11/22 | CDE |
| 恩格列净 | 四川科伦药业股份有限公司 | Y20180001382 | A | Exact ingredient | 2026/08/21 | CDE |
| 恩格列净 | 江苏豪森药业集团有限公司 | Y20180001426 | A | Exact ingredient | 2025/05/27 | CDE |
| 恩格列净 | 南京海纳医药科技有限公司 | Y20170001592 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/06No longer listed under review
江西施美药业股份有限公司
CYHS2502459
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2025/07/10
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/06No longer listed under review
江西施美药业股份有限公司
CYHS2502458
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2025/07/10
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/04Accepted
-
2026/10/28No longer listed under review
浙江江北药业有限公司
CYHS2502147
Fact date: 2026/10/28 · Site observation date: 2026/10/28
Accepted: 2025/06/17
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/09/01Accepted
-
2026/09/01Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Empagliflozin Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy